- Home
- INM vs PTIX Comparison
INM vs PTIX Comparison
Compare INM & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- PTIX
- Stock Information
- Founded
- INM 1981
- PTIX 1994
- Country
- INM Canada
- PTIX United States
- Employees
- INM N/A
- PTIX N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- PTIX Health Care
- Exchange
- INM Nasdaq
- PTIX Nasdaq
- Market Cap
- INM 3.2M
- PTIX 3.3M
- IPO Year
- INM N/A
- PTIX 2016
- Fundamental
- Price
- INM $3.05
- PTIX $3.55
- Analyst Decision
- INM
- PTIX
- Analyst Count
- INM 0
- PTIX 0
- Target Price
- INM N/A
- PTIX N/A
- AVG Volume (30 Days)
- INM 9.5M
- PTIX 183.9K
- Earning Date
- INM 05-12-2025
- PTIX 08-13-2025
- Dividend Yield
- INM N/A
- PTIX N/A
- EPS Growth
- INM N/A
- PTIX N/A
- EPS
- INM N/A
- PTIX N/A
- Revenue
- INM $4,920,990.00
- PTIX N/A
- Revenue This Year
- INM N/A
- PTIX N/A
- Revenue Next Year
- INM N/A
- PTIX N/A
- P/E Ratio
- INM N/A
- PTIX N/A
- Revenue Growth
- INM N/A
- PTIX N/A
- 52 Week Low
- INM $1.72
- PTIX $2.35
- 52 Week High
- INM $15.70
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- INM 51.86
- PTIX 47.24
- Support Level
- INM $3.32
- PTIX $3.46
- Resistance Level
- INM $5.50
- PTIX $4.19
- Average True Range (ATR)
- INM 0.37
- PTIX 0.26
- MACD
- INM 0.06
- PTIX 0.02
- Stochastic Oscillator
- INM 24.69
- PTIX 29.21
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.